RED+BLUE STRATEGIES lobbying for PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION (PCMA)

Filing 1st Quarter - Report

Reporting period

1st Quarter 2025

Jan 1 - Mar 31 · Posted Apr 5, 2025

Income

$50,000.00

What the client paid this registrant for the period.

Client based in

District of Columbia

Official filing document

Government bodies contacted 2

HOUSE OF REPRESENTATIVES
SENATE

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when.

Bills named in this filing 2

HR 1968
Full-Year Continuing Appropriations and Extensions Act, 2025
S 891
Bipartisan Health Care Act

Lobbying activity 3

Health Issues

H.R. 1968 - Full Year Continuing Resolution - Issues related to funding within the Department of Health and Human Services and its agencies for coverage of prescription medications. S. 891 - The Bipartisan Health Care Act - Policies impacting the treatment of pharmacy benefit managers in prescription medication supply chains. Issues related to pharmacy benefit managers in government and commercial insurance sectors.

Medicare/Medicaid

H.R. 1968 - Full Year Continuing Resolution - Issues related to funding within the Department of Health and Human Services and its agencies for coverage of prescription medications. S. 891 - The Bipartisan Health Care Act - Policies impacting the treatment of pharmacy benefit managers in prescription medication supply chains. Issues related to pharmacy benefit managers in government and commercial insurance sectors.

Pharmacy

H.R. 1968 - Full Year Continuing Resolution - Issues related to funding within the Department of Health and Human Services and its agencies for coverage of prescription medications. S. 891 - The Bipartisan Health Care Act - Policies impacting the treatment of pharmacy benefit managers in prescription medication supply chains. Issues related to pharmacy benefit managers in government and commercial insurance sectors.